Hippo Holdings Form 144 details 3,645-share planned NYSE sale

Rhea-AI Filing Summary

Hippo Holdings (HIPO) has a Form 144 notice covering a planned sale of 3,645 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an aggregate market value of 115,109.10 and are part of a larger base of 25,335,000 shares outstanding. The proposed sale date is 11/21/2025. The seller acquired 1,553 shares via restricted stock units on 05/15/2025 and 2,092 shares via performance stock units on 09/09/2025, both from the issuer. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about Hippo’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3645	115109.10	25335000	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2025	Restricted Stock Units	Issuer			1553	05/15/2025	N/A
Common	09/09/2025	Performance Stock Units	Issuer			2092	09/09/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Hippo Holdings (HIPO) disclose in this Form 144 filing?

The Form 144 filing for Hippo Holdings (HIPO) discloses a planned sale of 3,645 shares of common stock on the NYSE, with an aggregate market value of 115,109.10, from an affiliated holder relying on Rule 144.

How many Hippo Holdings (HIPO) shares are planned to be sold and at what value?

The notice covers the proposed sale of 3,645 common shares of Hippo Holdings, with an aggregate market value of 115,109.10 as stated in the filing.

When is the planned sale date for the Hippo (HIPO) shares under this Form 144?

The filing indicates an approximate date of sale of 11/21/2025 for the 3,645 Hippo Holdings common shares.

How were the Hippo Holdings (HIPO) shares being sold under Form 144 acquired?

The shares were acquired from the issuer through restricted stock units (1,553 shares on 05/15/2025) and performance stock units (2,092 shares on 09/09/2025), with payment indicated as N/A.

What is Hippo Holdings’ total shares outstanding referenced in this Form 144?

The Form 144 states that Hippo Holdings has 25,335,000 shares of the relevant class of common stock outstanding as a baseline figure.

Which broker is handling the planned Hippo (HIPO) Form 144 sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker for the proposed sale on the NYSE.

What representation does the seller make in this Hippo Holdings Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about Hippo Holdings’ current or prospective operations that has not been publicly disclosed.